EGFR and HER2 play an important role in carcinogenesis; overexpression of one or more members of the EGFR family has been shown in a number of malignancies, including breast, ovarian, non-small cell lung cancer and squamous cell carcinomas. Here, EGFR is linked to non-small cell lung carcinoma.